Biotech Growth N V - Oct 26, 2022 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role: 10%+ Owner
Signature: /s/Martin Gubler
Stock symbol: EPIX
Transactions as of: Oct 26, 2022
Transactions value $: $8,219,600
Form type: 4
Date filed: 10/28/2022, 02:57 PM
Previous filing: Oct 25, 2022
Next filing: Oct 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPIX	Common Shares	Purchase	$5.97M	+1.5M	+25.51%	$3.98	7.38M	Oct 26, 2022	Direct
transaction	EPIX	Common Shares	Purchase	$2.25M	+500K	+6.78%	$4.50	7.88M	Oct 27, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.